Clover Health Investments, Corp. (CLOV) Revenue History
Annual and quarterly revenue from 2018 to present
CLOV Revenue Over Time (2018–2025)
CLOV Revenue Growth History
6 of 7 years with positive growth- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- +64.5%
- FY2020 revenue growth
- +45.6%
- FY2021 revenue growth
- +118.8%
- FY2022 revenue growth
- -25.5%
- FY2023 revenue growth
- +15.0%
- FY2024 revenue growth
- +8.8%
- FY2025 revenue growth
- +40.3%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $744.2M | +61.0% |
| Q4 2025 | $487.7M | +44.7% |
| Q3 2025 | $496.6M | +50.1% |
| Q2 2025 | $477.6M | +34.1% |
| Q1 2025 | $462.3M | +33.3% |
| Q4 2024 | $337.0M | -34.0% |
| Q3 2024 | $331.0M | +8.2% |
| Q2 2024 | $356.3M | +11.3% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
CLOV's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CLOV Revenue Analysis (2018–2025)
Current Revenue & Growth
As of June 22, 2026, Clover Health Investments, Corp. (CLOV) generated trailing twelve-month (TTM) revenue of $2.21 billion, reflecting explosive growth of +61.0% year-over-year. The most recent quarter (Q1 2026) recorded $744.2 million in revenue, up 52.6% sequentially.
Historical Growth Trajectory
CLOV's 5-year compound annual growth rate (CAGR) stands at +23.4%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +20.6% is below the 5-year average, signalling a growth deceleration in recent years. Clover Health Investments, Corp.'s highest annual revenue of $1.92 billion was recorded in 2025, an all-time high.
Revenue by Segment
CLOV's revenue is primarily driven by Insurance Segment (100%). With over half of revenue concentrated in Insurance Segment, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including HUM (+14.1% YoY), CVS (+7.6% YoY), and ELV (+9.4% YoY) — CLOV has outperformed the peer group in revenue growth. Compare CLOV vs HUM →
CLOV Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLOVCurrent | $2.2B | +61.0% | +23.4% | -4.4% | |
 HUM | $129.7B | +14.1% | +10.9% | 1.1% | |
 CVS | $402.1B | +7.6% | +8.4% | 2.6% | |
 ELV | $199.1B | +9.4% | +10.3% | 4.1% | |
 CNC | $194.8B | +17.0% | +11.9% | -3.9% | |
 MOH | $45.4B | +7.7% | +18.5% | 1.7% |
CLOV Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.92B | +40.3% | $355.9M | 18.5% | $-85,529,000 | -4.4% |
| 2024 | $1.37B | +8.8% | $364.8M | 26.6% | $-45,749,000 | -3.3% |
| 2023 | $1.26B | +15.0% | $256.0M | 20.3% | $-205,329,000 | -16.3% |
| 2022 | $1.10B | -25.5% | $103.5M | 9.4% | $-286,664,000 | -26.1% |
| 2021 | $1.47B | +118.8% | $-79,182,000 | -5.4% | $-636,992,000 | -43.3% |
| 2020 | $672.9M | +45.6% | $82.8M | 12.3% | $-92,707,000 | -13.8% |
| 2019 | $462.3M | +64.5% | $12.6M | 2.7% | $-183,199,000 | -39.6% |
| 2018 | $281.0M | - | $281.0M | 100.0% | $-185,797,000 | -66.1% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CLOV — Frequently Asked Questions
Quick answers to the most common questions about buying CLOV stock.
Is CLOV's revenue growth accelerating or slowing?
CLOV revenue growth is accelerating. TTM revenue reached $2.2B, up +61.0% year-over-year — ahead of the 5-year CAGR of +23.4%. This indicates the business is expanding faster than its historical baseline.
What is CLOV's revenue history from 2018 to 2026?
Clover Health Investments, Corp. (CLOV) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $2.2B, growing at +61.0% YoY. The 5-year CAGR is +23.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CLOV's long-term revenue growth rate (CAGR)?
Clover Health Investments, Corp.'s 5-year revenue CAGR of +23.4% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +61.0% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CLOV.
Why does CLOV's quarterly revenue fluctuate?
CLOV quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Clover Health Investments, Corp.'s revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is CLOV's revenue distributed by segment?
CLOV reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CLOV's revenue compare to industry peers?
Clover Health Investments, Corp. (CLOV) with TTM revenue of $2.2B and +61.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.